375 related articles for article (PubMed ID: 27215200)
1. Therapeutic Potential of Polyphenols from Epilobium Angustifolium (Fireweed).
Schepetkin IA; Ramstead AG; Kirpotina LN; Voyich JM; Jutila MA; Quinn MT
Phytother Res; 2016 Aug; 30(8):1287-97. PubMed ID: 27215200
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Effect of Epilobium angustifolium Aqueous Extract on LNCaP Cell Proliferation in In Vitro and In Vivo Models.
Piwowarski JP; Bobrowska-Korczak B; Stanisławska I; Bielecki W; Wrzesien R; Granica S; Krupa K; Kiss AK
Planta Med; 2017 Oct; 83(14-15):1159-1168. PubMed ID: 28454190
[No Abstract] [Full Text] [Related]
3.
Nowak A; Zagórska-Dziok M; Ossowicz-Rupniewska P; Makuch E; Duchnik W; Kucharski Ł; Adamiak-Giera U; Prowans P; Czapla N; Bargiel P; Petriczko J; Markowska M; Klimowicz A
Molecules; 2021 Jun; 26(11):. PubMed ID: 34200200
[No Abstract] [Full Text] [Related]
4. Phytochemistry, pharmacology and traditional uses of different Epilobium species (Onagraceae): a review.
Granica S; Piwowarski JP; Czerwińska ME; Kiss AK
J Ethnopharmacol; 2014 Oct; 156():316-46. PubMed ID: 25196824
[TBL] [Abstract][Full Text] [Related]
5. Inter-population and inter-organ distribution of the main polyphenolic compounds of Epilobium angustifolium.
Baert N; Kim J; Karonen M; Salminen JP
Phytochemistry; 2017 Feb; 134():54-63. PubMed ID: 27866749
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the therapeutic effect against benign prostatic hyperplasia and the active constituents from Epilobium angustifolium L.
Deng L; Zong W; Tao X; Liu S; Feng Z; Lin Y; Liao Z; Chen M
J Ethnopharmacol; 2019 Mar; 232():1-10. PubMed ID: 30529422
[TBL] [Abstract][Full Text] [Related]
7. Epilobium spp: Pharmacology and Phytochemistry.
Vitalone A; Allkanjari O
Phytother Res; 2018 Jul; 32(7):1229-1240. PubMed ID: 29575111
[TBL] [Abstract][Full Text] [Related]
8. Oenothein B's contribution to the anti-inflammatory and antioxidant activity of Epilobium sp.
Kiss AK; Bazylko A; Filipek A; Granica S; Jaszewska E; Kiarszys U; Kośmider A; Piwowarski J
Phytomedicine; 2011 May; 18(7):557-60. PubMed ID: 21112753
[TBL] [Abstract][Full Text] [Related]
9. Biological Activity of an
Kowalik K; Polak-Berecka M; Prendecka-Wróbel M; Pigoń-Zając D; Niedźwiedź I; Szwajgier D; Baranowska-Wójcik E; Waśko A
Molecules; 2022 Feb; 27(3):. PubMed ID: 35164271
[TBL] [Abstract][Full Text] [Related]
10. Effect of Epilobium angustifolium L. extracts and polyphenols on cell proliferation and neutral endopeptidase activity in selected cell lines.
Kiss A; Kowalski J; Melzig MF
Pharmazie; 2006 Jan; 61(1):66-9. PubMed ID: 16454210
[TBL] [Abstract][Full Text] [Related]
11. Extracts from Epilobium sp. herbs, their components and gut microbiota metabolites of Epilobium ellagitannins, urolithins, inhibit hormone-dependent prostate cancer cells-(LNCaP) proliferation and PSA secretion.
Stolarczyk M; Piwowarski JP; Granica S; Stefańska J; Naruszewicz M; Kiss AK
Phytother Res; 2013 Dec; 27(12):1842-8. PubMed ID: 23436427
[TBL] [Abstract][Full Text] [Related]
12. In vivo bioactivity assessment on Epilobium species: A particular focus on Epilobium angustifolium and its components on enzymes connected with the healing process.
Karakaya S; Süntar I; Yakinci OF; Sytar O; Ceribasi S; Dursunoglu B; Ozbek H; Guvenalp Z
J Ethnopharmacol; 2020 Nov; 262():113207. PubMed ID: 32730870
[TBL] [Abstract][Full Text] [Related]
13. Compounds from Epilobium angustifolium inhibit the specific metallopeptidases ACE, NEP and APN.
Kiss A; Kowalski J; Melzig MF
Planta Med; 2004 Oct; 70(10):919-23. PubMed ID: 15490319
[TBL] [Abstract][Full Text] [Related]
14. Vegetational variation of phenolic compounds in Epilobium angustifolium.
Jürgenson S; Matto V; Raal A
Nat Prod Res; 2012; 26(20):1951-3. PubMed ID: 22149976
[TBL] [Abstract][Full Text] [Related]
15. HPLC-ESI-MS/MS analysis of phenolics and in vitro antioxidant activity of Epilobium angustifolium L.
Deng LQ; Zhou SY; Mao JX; Liu S; Lan XZ; Liao ZH; Chen M
Nat Prod Res; 2018 Jun; 32(12):1432-1435. PubMed ID: 28637366
[TBL] [Abstract][Full Text] [Related]
16. Induction of neutral endopeptidase activity in PC-3 cells by an aqueous extract of Epilobium angustifolium L. and oenothein B.
Kiss A; Kowalski J; Melzig MF
Phytomedicine; 2006 Mar; 13(4):284-9. PubMed ID: 16492533
[TBL] [Abstract][Full Text] [Related]
17. Inventing a herbal tradition: The complex roots of the current popularity of Epilobium angustifolium in Eastern Europe.
Sõukand R; Mattalia G; Kolosova V; Stryamets N; Prakofjewa J; Belichenko O; Kuznetsova N; Minuzzi S; Keedus L; Prūse B; Simanova A; Ippolitova A; Kalle R
J Ethnopharmacol; 2020 Jan; 247():112254. PubMed ID: 31580942
[TBL] [Abstract][Full Text] [Related]
18. Oenothein B, a cyclic dimeric ellagitannin isolated from Epilobium angustifolium, enhances IFNγ production by lymphocytes.
Ramstead AG; Schepetkin IA; Quinn MT; Jutila MA
PLoS One; 2012; 7(11):e50546. PubMed ID: 23226309
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the effect of Epilobium extracts on human cell proliferation.
Vitalone A; McColl J; Thome D; Costa LG; Tita B
Pharmacology; 2003 Oct; 69(2):79-87. PubMed ID: 12928581
[TBL] [Abstract][Full Text] [Related]
20. Polyphenol composition and antioxidant capacity of Epilobium species.
Hevesi Tóth B; Blazics B; Kéry A
J Pharm Biomed Anal; 2009 Jan; 49(1):26-31. PubMed ID: 19013046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
